24-Hour Crisis Hotline: (877)SAFEGBC or (877)723-3422 Mental Health & Substance Abuse Issues

6502 Nursery Drive, Suite 100
Victoria, TX 77904
(361)575-0611
(800)421-8825
Fax: (361)578-5500

Diabetes
Resources
Basic InformationLatest News
Next-Gen Artificial Pancreas Boosts Blood Sugar ControlHurricanes Raise Death Risk for Older Diabetics, Even Years LaterYou've Lost the Weight -- Now Keep It Off to Keep Diabetes at BayCould a Pill Replace Insulin Shots?High-Fiber Diet Tied to Lower Heart Risk in Diabetes PatientsJust a Little Weight Loss Can Put Diabetes Into RemissionAffordable Care Act Insured Millions of Uninsured DiabeticsOlder Diabetics May Be Getting Too Much InsulinIt Takes Less Weight to Trigger Diabetes in Minorities Than WhitesFDA OKs New Pill for Type 2 DiabetesAHA News: These Diets Helped Women With Diabetes Cut Heart Attack, Stroke RiskKeeping Blood Sugar Steady Helps You Live Longer With DiabetesAre Shorter Folks at Higher Risk for Type 2 Diabetes?Diabetes Control Has Stalled Across U.S.Fish Oil Not a Magic Pill Against DiabetesAsian Study Finds Diabetes, Heart Failure a Dangerous DuoCaring Doctors Can Be Life-Changing for Diabetic PatientsKeto Diet May Help Control Type 2 DiabetesHealth Tip: Living With HypoglycemiaHealth Tip: Understanding PrediabetesFDA Approves First Needle-Free 'Rescue' Drug for Low Blood Sugar EpisodesDiabetes Raises Heart Failure Risk More in Women Than MenCan You Live Well With Type 1 Diabetes for 81 Years? Just Ask Don RayEasing Depression Can Bring Longer Life to People With DiabetesMedtronic Recalls Some Insulin Pumps as FDA Warns They Could Be HackedFDA Approves Victoza Injection for Children 10 Years and OlderCommon Infant Vaccine May Also Shield Kids From Type 1 DiabetesType 1 Diabetes Might Affect Young Kids' Brain DevelopmentDrug May Help Delay Onset of Type 1 DiabetesVitamin D Supplements Don't Prevent Type 2 Diabetes: StudyWhat and How You Eat Affects Your Odds for Type 2 DiabetesAHA News: Diabetes and Heart Failure Are Linked; Treatment Should Be TooMidlife Diabetes Can Really Raise Your Odds for Stroke Years LaterTight Diabetes Control Alone May Not Benefit the Heart Long-TermOpen Communication Helps Teens Manage Type 1 DiabetesNew Gene Variants for Type 2 Diabetes FoundPost-Hospital Low Blood Sugar a Danger to DiabeticsAHA News: Why Are Women With Diabetes at Greater Risk for Poor Heart Health?Newer Diabetes Drugs Linked to 'Flesh-Eating' Genital InfectionAHA News: Study Backs Lower Blood Pressure Target for People With DiabetesNewer Diabetes Drug Shows Promise in Kids, TeensNo 'One-Size-Fits-All' Diet for Diabetics, Expert Panel SaysMicrobes in Diabetic Foot Ulcers May Help Predict Treatment SuccessCommon Diabetes Drug May Also Shield Kidneys, HeartThe Earlier You Develop Type 2 Diabetes, the Greater Your Heart RisksHigh Insulin Costs Come Under Fire on Capitol HillType 1 Diabetics Often Unaware of Low Blood Sugar EpisodesCommon Diabetes Test May Often Miss the MarkHealth Tip: Reading Food Labels for DiabeticsWhich Type of Exercise Might Lower Your Diabetes Risk?
Links
Related Topics

Medical Disorders

Newer Diabetes Drug Shows Promise in Kids, Teens

HealthDay News
by -- Robert Preidt
Updated: Apr 30th 2019

new article illustration

TUESDAY, April 30, 2019 (HealthDay News) -- A type 2 diabetes drug for adults also controls blood sugar levels in children and teens with the disease, researchers report.

Type 2 diabetes is on the rise among children and teens, but they have fewer treatment choices than adults, the study authors said. Currently, the only drugs approved for treatment of children and teens with type 2 diabetes are metformin and insulin.

This study, led by researchers at Yale University, looked at how the drug liraglutide (Victoza) affected blood sugar and glycated hemoglobin (or A1c) levels in patients aged 10 to 16 with type 2 diabetes who were already taking metformin with or without insulin.

Half of the patients took metformin plus liraglutide, and the other half took metformin plus an inactive placebo. The participants' blood sugar and A1c levels were checked after six months and one year.

For those with type 2 diabetes, an A1c level below 7% means their diabetes is relatively well-controlled, the study authors noted.

After six months, those in the liraglutide group had substantially lower blood sugar levels and their A1c levels were 1.1 percentage points lower than those in the placebo group, the findings showed.

After one year, the liraglutide group had A1c levels 1.3 percentage points lower than the placebo group, which had an average 0.5 percentage point increase.

The investigators also found that, after one year, nearly two-thirds of the liraglutide group had A1c levels under the 7% target, compared to one-third of the placebo group.

The study, published online April 28 in the New England Journal of Medicine, was funded by the drug's maker, Novo Nordisk.

The findings could be "transformational" for children and teens with type 2 diabetes, according to study first author Dr. William Tamborlane, a pediatric endocrinologist at Yale.

Metformin is the most popular initial treatment for type 2 diabetes in children and teens, but it often leads to an early loss of blood sugar control, and add-on treatment with insulin usually fails to lower blood sugar levels, the researchers explained in a university news release.

"As a result of this study, we anticipate that youth with type 2 diabetes will soon have a third option that has not previously been available," Tamborlane said.

More information

The U.S. Centers for Disease Control and Prevention explains how to prevent type 2 diabetes in children.